Xoma | XOMA - Trade Debtors


Xoma reported $14.78M in Trade Debtors for its fiscal quarter ending in June of 2024.





Trade Debtors Change Date
AbbVie USD 12.77B 132M Sep/2025
Agenus USD 22.44M 1.14M Dec/2025
Agios Pharmaceuticals USD 10.58M 5.55M Dec/2025
Ardelyx USD 71.85M 4.76M Dec/2025
aTyr Pharma USD 296.74M 295.7M Dec/2025
BioMarin Pharmaceutical USD 908.21M 117.95M Dec/2025
Celldex Therapeutics USD 2.02M 1.92M Dec/2025
Curis USD 2.55M 400K Jun/2024
Eli Lilly USD 19.46B 2.25B Sep/2025
Emergent BioSolutions USD 290.1M 134.2M Jun/2023
Incyte USD 1.02B 128.52M Dec/2025
MacroGenics USD 13.37M 55.86M Dec/2025
Novartis USD 12.29B 3.3B Dec/2025
Novartis USD 12.29B 3.3B Dec/2025
Pfizer USD 18.12B 2.02B Sep/2025
Prothena USD 5.16M 0 Dec/2023
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Xoma USD 14.78M 4.96M Jun/2024